<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title42.html">
                                    Title 42
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/42CFR426.html">Part 426
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 426.500  Procedure for filing an acceptable complaint
                            </h3>
                            <p class="depth1"><em>(a)</em> The complaint. An aggrieved party may initiate a review of an  NCD by filing a written complaint with the Department of Health and  Human Services Departmental Appeals Board.</p><p class="depth1"><em>(b)</em> Timeliness of a complaint. An NCD complaint is not considered  timely unless it is filed with the Board within--</p><p class="depth2"><em>(1)</em> 6 months of the written statement from each aggrieved party's  treating physician, in the case of aggrieved parties who choose to file  an NCD challenge before receiving the service; or</p><p class="depth2"><em>(2)</em> 120 days of the initial denial notice, in the case of aggrieved  parties who choose to file an NCD challenge after receiving the service.</p><p class="depth1"><em>(c)</em> Components of a valid complaint. A complaint must include the  following:</p><p class="depth2"><em>(1)</em> Beneficiary-identifying information:</p><p class="depth3"><em>(i)</em> Name.</p><p class="depth3"><em>(ii)</em> Mailing address.</p><p class="depth3"><em>(iii)</em> State of residence, if different from mailing address.</p><p class="depth3"><em>(iv)</em> Telephone number, if any.</p><p class="depth3"><em>(v)</em> Health Insurance Claim number, if applicable.</p><p class="depth3"><em>(vi)</em> Email address, if applicable.</p><p class="depth2"><em>(2)</em> If the beneficiary has a representative, the representative's  indetifying information must include the following:</p><p class="depth3"><em>(i)</em> Name.</p><p class="depth3"><em>(ii)</em> Address.</p><p class="depth3"><em>(iii)</em> Telephone number.</p><p class="depth3"><em>(iv)</em> E-mail address (if any)</p><p class="depth3"><em>(v)</em> Copy of the written authorization to represent the beneficiary.</p><p class="depth2"><em>(3)</em> Treating physician written statement. A copy of a written  statement from the treating physician that the   beneficiary needs the service that is the subject of the NCD. This  statement may be in the form of a written order for the service or other  documentation from the beneficiary's medical record (such as progress  notes or discharge summary) indicating that the beneficiary needs the  service.</p><p class="depth2"><em>(4)</em> NCD-identifying information:</p><p class="depth3"><em>(i)</em> Title of NCD being challenged.</p><p class="depth3"><em>(ii)</em> The specific provision or provisions of the NCD adversely  affecting the aggrieved party.</p><p class="depth2"><em>(5)</em> Aggrieved party statement. A statement from the aggrieved party  explaining what service is needed and why the aggrieved party thinks  that the provision(s) of the NCD is (are) not valid under the  reasonableness standard.</p><p class="depth2"><em>(6)</em> Clinical or scientific evidence. </p><p class="depth3"><em>(i)</em> Copies of clinical or  scientific evidence that supports the complaint and an explanation for  why the aggrieved party thinks that this evidence shows that the NCD is  not reasonable.</p><p class="depth3"><em>(ii)</em> Any documents or portions of documents that include proprietary  data must be marked ``proprietary data,'' and include a legal basis for  that assertion.</p><p class="depth3"><em>(iii)</em> Proprietary data submitted by a manufacturer concerning a drug  or device for which the manufacturer has submitted information to the  Food and Drug Administration, must be considered and given substantive  weight only when supported by an affidavit certifying that the  submission contains true and correct copies of all data submitted by the  manufacturer to the Food and Drug Administration in relation to that  drug or device.</p><p class="depth1"><em>(d)</em> Joint complaints--</p><p class="depth2"><em>(1)</em> Conditions for a joint complaint. Two or  more aggrieved parties may initiate the review of an NCD by filing a  single written complaint with the Board if all of the following  conditions are met:</p><p class="depth3"><em>(i)</em> Each aggrieved party named in the joint complaint has a similar  medical condition or there are other bases for combining the complaints.</p><p class="depth3"><em>(ii)</em> Each aggrieved party named in the joint complaint is filing the  complaint in regard to the same provision(s) of the same NCD.</p><p class="depth2"><em>(2)</em> Components of a valid joint complaint. A joint complaint must  contain the following information:</p><p class="depth3"><em>(i)</em> The beneficiary-identifying information described in paragraph  (c)(1) of this section for each aggrieved party named in the joint  complaint.</p><p class="depth3"><em>(ii)</em> The NCD-identifying information described in paragraph (c)(2)  of this section.</p><p class="depth3"><em>(iii)</em> The documentation described in paragraphs (c)(3) and (c)(4) of  this section.</p><p class="depth2"><em>(3)</em> Timeliness of a joint complaint. Aggrieved parties, who choose  to seek review of an NCD--</p><p class="depth3"><em>(i)</em> Before receiving the service, must file with the Board a joint  complaint within 6 months of the written statement from each aggrieved  party's treating physician; or</p><p class="depth3"><em>(ii)</em> After receiving the service, must file with the Board a  complaint within 120 days of each aggrieved party's initial denial  notice.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
